Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Some pathogenic characters of paratyphoid Salmonella enterica strains isolated from poultry.

Bertelloni F, Tosi G, Massi P, Fiorentini L, Parigi M, Cerri D, Ebani VV.

Asian Pac J Trop Med. 2017 Dec;10(12):1161-1166. doi: 10.1016/j.apjtm.2017.10.023. Epub 2017 Oct 31.

2.

Think globally, act locally: Phylodynamic reconstruction of infectious bronchitis virus (IBV) QX genotype (GI-19 lineage) reveals different population dynamics and spreading patterns when evaluated on different epidemiological scales.

Franzo G, Massi P, Tucciarone CM, Barbieri I, Tosi G, Fiorentini L, Ciccozzi M, Lavazza A, Cecchinato M, Moreno A.

PLoS One. 2017 Sep 7;12(9):e0184401. doi: 10.1371/journal.pone.0184401. eCollection 2017.

3.

H7N7 Highly Pathogenic Avian Influenza in Poultry Farms in Italy in 2016.

Mulatti P, Zecchin B, Monne I, Vieira JT, Dorotea T, Terregino C, Lorenzetto M, Piccolomini LL, Santi A, Massi P, Bonfanti L, Marangon S.

Avian Dis. 2017 Jun;61(2):261-266. doi: 10.1637/11540-112516-Case.1.

PMID:
28665731
4.

Genetic Diversity of Highly Pathogenic Avian Influenza A(H5N8/H5N5) Viruses in Italy, 2016-17.

Fusaro A, Monne I, Mulatti P, Zecchin B, Bonfanti L, Ormelli S, Milani A, Cecchettin K, Lemey P, Moreno A, Massi P, Dorotea T, Marangon S, Terregino C.

Emerg Infect Dis. 2017 Sep;23(9):1543-1547. doi: 10.3201/eid2309.170539. Epub 2017 Sep 17.

5.

A novel variant of the infectious bronchitis virus resulting from recombination events in Italy and Spain.

Moreno A, Franzo G, Massi P, Tosi G, Blanco A, Antilles N, Biarnes M, Majó N, Nofrarías M, Dolz R, Lelli D, Sozzi E, Lavazza A, Cecchinato M.

Avian Pathol. 2017 Feb;46(1):28-35. doi: 10.1080/03079457.2016.1200011. Epub 2016 Oct 24.

PMID:
27329854
6.

Unexpected Interfarm Transmission Dynamics during a Highly Pathogenic Avian Influenza Epidemic.

Fusaro A, Tassoni L, Milani A, Hughes J, Salviato A, Murcia PR, Massi P, Zamperin G, Bonfanti L, Marangon S, Cattoli G, Monne I.

J Virol. 2016 Jun 24;90(14):6401-6411. doi: 10.1128/JVI.00538-16. Print 2016 Jul 15.

7.

Full Genome Sequence-Based Comparative Study of Wild-Type and Vaccine Strains of Infectious Laryngotracheitis Virus from Italy.

Piccirillo A, Lavezzo E, Niero G, Moreno A, Massi P, Franchin E, Toppo S, Salata C, Palù G.

PLoS One. 2016 Feb 18;11(2):e0149529. doi: 10.1371/journal.pone.0149529. eCollection 2016.

8.

Highly pathogenic H7N7 avian influenza in Italy.

Bonfanti L, Monne I, Tamba M, Santucci U, Massi P, Patregnani T, Loli Piccolomini L, Natalini S, Ferri G, Cattoli G, Marangon S.

Vet Rec. 2014 Apr 12;174(15):382. doi: 10.1136/vr.102202. Epub 2014 Mar 21. No abstract available. Erratum in: Vet Rec. 2014 May 31;174(22):562.

PMID:
24659030
9.

Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect.

Solinas M, Massi P, Cinquina V, Valenti M, Bolognini D, Gariboldi M, Monti E, Rubino T, Parolaro D.

PLoS One. 2013 Oct 21;8(10):e76918. doi: 10.1371/journal.pone.0076918. eCollection 2013.

10.

Exploring the larval transcriptome of the common sole (Solea solea L.).

Ferraresso S, Bonaldo A, Parma L, Cinotti S, Massi P, Bargelloni L, Gatta PP.

BMC Genomics. 2013 May 10;14:315. doi: 10.1186/1471-2164-14-315.

11.

Development of a feed additive to reduce caecal Campylobacter jejuni in broilers at slaughter age: from in vitro to in vivo, a proof of concept.

Grilli E, Vitari F, Domeneghini C, Palmonari A, Tosi G, Fantinati P, Massi P, Piva A.

J Appl Microbiol. 2013 Feb;114(2):308-17. doi: 10.1111/jam.12053. Epub 2012 Nov 21.

12.

Cannabidiol inhibits angiogenesis by multiple mechanisms.

Solinas M, Massi P, Cantelmo AR, Cattaneo MG, Cammarota R, Bartolini D, Cinquina V, Valenti M, Vicentini LM, Noonan DM, Albini A, Parolaro D.

Br J Pharmacol. 2012 Nov;167(6):1218-31. doi: 10.1111/j.1476-5381.2012.02050.x.

13.

Cannabidiol as potential anticancer drug.

Massi P, Solinas M, Cinquina V, Parolaro D.

Br J Clin Pharmacol. 2013 Feb;75(2):303-12. doi: 10.1111/j.1365-2125.2012.04298.x. Review.

14.

Influenza A pandemic (H1N1) 2009 virus outbreak in a cat colony in Italy.

Fiorentini L, Taddei R, Moreno A, Gelmetti D, Barbieri I, De Marco MA, Tosi G, Cordioli P, Massi P.

Zoonoses Public Health. 2011 Dec;58(8):573-81. doi: 10.1111/j.1863-2378.2011.01406.x. Epub 2011 Apr 11.

PMID:
21824359
15.

Microencapsulated sorbic acid and nature-identical compounds reduced Salmonella Hadar and Salmonella Enteritidis colonization in experimentally infected chickens.

Grilli E, Tugnoli B, Formigoni A, Massi P, Fantinati P, Tosi G, Piva A.

Poult Sci. 2011 Aug;90(8):1676-82. doi: 10.3382/ps.2011-01441.

PMID:
21753203
16.

Multilocus variable-number of tandem-repeats analysis of Salmonella enterica serotype Gallinarum and comparison with pulsed-field gel electrophoresis genotyping.

Bergamini F, Iori A, Massi P, Pongolini S.

Vet Microbiol. 2011 May 5;149(3-4):430-6. doi: 10.1016/j.vetmic.2010.12.002. Epub 2010 Dec 8.

PMID:
21208755
17.

Molecular mechanisms involved in the antitumor activity of cannabinoids on gliomas: role for oxidative stress.

Massi P, Valenti M, Solinas M, Parolaro D.

Cancers (Basel). 2010 May 26;2(2):1013-26. doi: 10.3390/cancers2021013.

18.

Cellular mechanisms underlying the interaction between cannabinoid and opioid system.

Parolaro D, Rubino T, Viganò D, Massi P, Guidali C, Realini N.

Curr Drug Targets. 2010 Apr;11(4):393-405. Review.

PMID:
20017730
19.

Triage: do we still believe in multiple tier?

Bambi S, Ruggeri M, Becattini G, Tramontana S, Massi P, Lumini E, Mazzoni F, Casanova B.

J Emerg Nurs. 2009 Jan;35(1):3-4. doi: 10.1016/j.jen.2008.10.016. No abstract available.

PMID:
19203672
20.

Expression and function of the endocannabinoid system in glial cells.

Massi P, Valenti M, Bolognini D, Parolaro D.

Curr Pharm Des. 2008;14(23):2289-98. Review.

PMID:
18781979
21.

Cannabinoids as potential new therapy for the treatment of gliomas.

Parolaro D, Massi P.

Expert Rev Neurother. 2008 Jan;8(1):37-49. Review.

PMID:
18088200
22.

5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid.

Massi P, Valenti M, Vaccani A, Gasperi V, Perletti G, Marras E, Fezza F, Maccarrone M, Parolaro D.

J Neurochem. 2008 Feb;104(4):1091-100. Epub 2007 Nov 17.

23.

CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour.

Rubino T, Guidali C, Vigano D, Realini N, Valenti M, Massi P, Parolaro D.

Neuropharmacology. 2008 Jan;54(1):151-60. Epub 2007 Jul 6. Erratum in: Neuropharmacology. 2008 Aug;55(2):247.

PMID:
17692344
24.
25.

Cannabinoids, immune system and cytokine network.

Massi P, Vaccani A, Parolaro D.

Curr Pharm Des. 2006;12(24):3135-46. Review.

PMID:
16918439
26.

The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells.

Massi P, Vaccani A, Bianchessi S, Costa B, Macchi P, Parolaro D.

Cell Mol Life Sci. 2006 Sep;63(17):2057-66.

PMID:
16909207
27.

Pharmacodynamics and pharmacokinetics of flumequine in pigs after single intravenous and intramuscular administration.

Villa R, Cagnardi P, Acocella F, Massi P, Anfossi P, Asta F, Carli S.

Vet J. 2005 Jul;170(1):101-7.

PMID:
15993793
28.

Detection of influenza A virus by RT-PCR and standard methods in experimental infection of Ducks.

Foni E, Chiapponi C, Lori D, De Marco MA, Delogu M, Raffini E, Massi P.

New Microbiol. 2005 Jan;28(1):31-5.

PMID:
15782624
29.

Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism.

Vaccani A, Massi P, Colombo A, Rubino T, Parolaro D.

Br J Pharmacol. 2005 Apr;144(8):1032-6.

30.

The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro.

Sacerdote P, Martucci C, Vaccani A, Bariselli F, Panerai AE, Colombo A, Parolaro D, Massi P.

J Neuroimmunol. 2005 Feb;159(1-2):97-105. Epub 2004 Dec 1.

PMID:
15652407
31.

Cannabinoids and opioids share cAMP pathway in rat splenocytes.

Massi P, Vaccani A, Rubino T, Parolaro D.

J Neuroimmunol. 2003 Dec;145(1-2):46-54.

PMID:
14644030
32.

Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines.

Massi P, Vaccani A, Ceruti S, Colombo A, Abbracchio MP, Parolaro D.

J Pharmacol Exp Ther. 2004 Mar;308(3):838-45. Epub 2003 Nov 14.

33.

Mu opioid receptor signaling in morphine sensitization.

Viganò D, Rubino T, Di Chiara G, Ascari I, Massi P, Parolaro D.

Neuroscience. 2003;117(4):921-9.

PMID:
12654343
34.

Cellular mechanisms of Delta 9-tetrahydrocannabinol behavioural sensitization.

Rubino T, Viganò D, Massi P, Parolaro D.

Eur J Neurosci. 2003 Jan;17(2):325-30.

PMID:
12542669
35.

Cannabimimetic activity, binding, and degradation of stearoylethanolamide within the mouse central nervous system.

Maccarrone M, Cartoni A, Parolaro D, Margonelli A, Massi P, Bari M, Battista N, Finazzi-Agrò A.

Mol Cell Neurosci. 2002 Sep;21(1):126-40.

PMID:
12359156
36.

Endocannabinoids in the immune system and cancer.

Parolaro D, Massi P, Rubino T, Monti E.

Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):319-32. Review.

PMID:
12052046
37.

The psychoactive ingredient of marijuana induces behavioural sensitization.

Rubino T, Viganò D, Massi P, Parolaro D.

Eur J Neurosci. 2001 Sep;14(5):884-6.

PMID:
11576193
38.
39.

A longitudinal study of velogenic Newcastle disease virus genotypes isolated in Italy between 1960 and 2000.

Herczeg J, Pascucci S, Massi P, Luini M, Selli L, Capua I, Lomniczi B.

Avian Pathol. 2001 Apr;30(2):163-8. doi: 10.1080/03079450120044000.

PMID:
19184891
42.

Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome.

Rubino T, Massi P, Viganò D, Fuzio D, Parolaro D.

Life Sci. 2000 Apr 21;66(22):2213-9.

PMID:
10834304
43.

Chronic delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions.

Rubino T, Vigano' D, Massi P, Spinello M, Zagato E, Giagnoni G, Parolaro D.

Neuropharmacology. 2000 Apr 27;39(7):1331-6.

PMID:
10760375
44.

Relative involvement of cannabinoid CB(1) and CB(2) receptors in the Delta(9)-tetrahydrocannabinol-induced inhibition of natural killer activity.

Massi P, Fuzio D, Viganò D, Sacerdote P, Parolaro D.

Eur J Pharmacol. 2000 Jan 17;387(3):343-7.

PMID:
10650181
45.

Immune function alterations in mice tolerant to delta9-tetrahydrocannabinol: functional and biochemical parameters.

Massi P, Sacerdote P, Ponti W, Fuzio D, Manfredi B, Viganó D, Rubino T, Bardotti M, Parolaro D.

J Neuroimmunol. 1998 Dec 1;92(1-2):60-6.

PMID:
9916880
46.

Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression.

Rubino T, Patrini G, Massi P, Fuzio D, Viganò D, Giagnoni G, Parolaro D.

J Pharmacol Exp Ther. 1998 May;285(2):813-9.

47.

Modulation of rat brain cannabinoid receptors after chronic morphine treatment.

Rubino T, Tizzoni L, Viganò D, Massi P, Parolaro D.

Neuroreport. 1997 Oct 20;8(15):3219-23.

PMID:
9351646
48.

Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study.

Massi P, Patrini G, Rubino T, Fuzio D, Parolaro D.

Pharmacol Biochem Behav. 1997 Sep;58(1):73-8.

PMID:
9264073
49.

Chronic treatment with a synthetic cannabinoid CP-55,940 alters G-protein expression in the rat central nervous system.

Rubino T, Patrini G, Parenti M, Massi P, Parolaro D.

Brain Res Mol Brain Res. 1997 Mar;44(2):191-7.

PMID:
9073160
50.

Changes in opioid receptor density on murine splenocytes induced by in vivo treatment with morphine and methadone.

Patrini G, Massi P, Ricevuti G, Mazzone A, Fossati G, Mazzucchelli I, Gori E, Parolaro D.

J Pharmacol Exp Ther. 1996 Oct;279(1):172-6.

PMID:
8858990

Supplemental Content

Support Center